An international study co-led by University of Calgary researchers found that advanced insulin -delivery technology significantly improves glucose control in pregnant women with Type 1 diabetes , supporting better health outcomes for both mothers and newborns.

The technology, known as automated insulin delivery (AID), mimics a healthy pancreas. The system automatically adjusts the amount of insulin given by a pump in real-time, based on current and predicted glucose levels.

“For pregnant women with Type 1 diabetes, keeping glucose within a healthy range is very important to the health of the woman and fetus,” says an endocrinologist at Foothills Medical Centre in Calgary and Cumming School of Medicine researcher Dr. Lois Donovan, MD, the study co-principal investigator.

In a multice

See Full Page